查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529758

电泳市场规模、份额、趋势分析报告：2024-2030 年按产品、应用、最终用途、地区和细分市场进行的预测

Electrophoresis Market Size, Share & Trends Analysis Report By Product (Electrophoresis Reagents, Systems), By Application, By End-use (Academic and Research Institutes), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

电泳市场规模及趋势

2023年全球电泳市场规模预估为31.7646亿美元，预估2024年至2030年复合年增长率为5.3%。推动这一增长的关键因素包括心血管疾病和癌症等慢性病的盛行率不断上升、对个人化药物的需求不断增长以及由于技术进步而加强的产学合作。此外，基因组学和蛋白​​质组学研究资金的增加以及临床实验室数量的增加可能会在预测期内推动市场。

癌症和感染疾病患者病率的上升增加了早期诊断的需求。 2024年2月，世界卫生组织估计，到2050年，全球癌症病例数将达到3,500万人。这种日益普遍的现象正在推动对先进诊断和治疗技术（包括电泳试剂和系统）的需求。电泳是癌症研究、诊断和监测中使用的重要技术，可以分离和分析蛋白质、核酸和其他生物分子。肺癌是全球癌症死亡的第一大原因，2022年将导致180万人死亡，占所有癌症死亡的18.7%。

学术机构和产业之间的合作正在推动电泳技术的创新，特别是在基因组学、蛋白质组学和个人化医疗领域。这些合作伙伴关係利用先进的电泳技术来识别生物标誌物，在分子层面上研究疾病机制，并开发针对个体遗传特征的标靶治疗。此外，高性能电泳系统在临床诊断和药物研究中的整合不断增加，加速了更精确、更有效率的分析方法的开发。 2022 年 5 月在 PLOS ONE 杂誌上发表的一项最新研究强调了使用凝胶电泳来识别与肺癌 Ta 亚型的肿瘤进展和分子特异性相关的关键蛋白质。这项技术使研究人员能够识别癌细胞中的蛋白质，这有助于准确诊断，并有助于开发针对特定肺癌部位的标靶治疗。

电泳套件和试剂的技术进步提高了电泳技术在各种科学和临床应用中的效率、准确性和多功能性，彻底改变了电泳技术。其中一项关键进展是用于凝胶电泳的新型凝胶基质的配製，可提高 DNA、RNA 和蛋白质等生物分子的分辨率并加快分离速度。例如，2022 年 9 月，为研究人员提供科学设备的领先供应商 miniPCR bio 宣布推出 BanditTM STEM 电泳，这是一种创新的教育工具，使学生能够以实惠的价格组装和操作功能齐全的凝胶电泳套件。该套件旨在促进 STEM 教育领域的体验式学习。

该市场的进一步特点是自动化系统和机器人技术在电泳平台中的集成，从而简化了实验室工作流程。自动化电泳设备利用基于微流体晶片的技术，将蛋白质和核酸等生物分子的萤光检测、电泳分离和资料分析无缝整合到一个平台中。例如，Experion 分析晶片采用 Caliper Life Sciences 开发的 LabChip 技术。此微流体晶片充当强大的小型实验室，封装了多个大型桌上型分析仪的功能。每个晶片都具有连接样品孔、分离通道和缓衝孔的微通道网路。

此外，自动化的凝胶负载、样品处理和资料分析过程可最大限度地减少人为错误并提高重现性，使电泳对研究人员和临床医生来说更加容易和可靠。此外，单细胞蛋白质组学和血浆生物标记发现的进步也推动了对具有更高通量和重现性的电泳技术的需求。电泳工作流程的自动化和小型化是满足这些不断变化的研究需求的关键焦点部分。

政府倡议、增加的资金以及对基因组学和蛋白​​质组学的大量投资也在推动市场成长。耶鲁大学基因组学和蛋白​​质组学中心以及国家癌症研究所的临床蛋白质组学肿瘤分析联盟等重大倡议为推进基因组学和蛋白​​质组学研究提供了大量资金。因此，对支援这些工作的高性能电泳试剂和系统的需求不断增长。此外，2023年10月，加拿大政府宣布将在五年内投资1,500万美元建立泛加拿大基因组图书馆，这是该国第一个国家集中式基因组资料管理系统。该图书馆将使疾病特别是罕见疾病的更个人化的治疗成为可能。旨在建立此类研究能力的倡议有望推动电泳系统和试剂的需求。

全球电泳市场报告细分

该报告预测了全球、区域和国家层面的收益成长，并对 2018 年至 2030 年各子区隔的最新行业趋势进行了分析。在这项研究中，Grand View Research, Inc. 根据产品、应用、最终用途和地区对全球电泳市场报告进行了细分。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章电泳市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 电泳市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章电泳市场：依产品分类的估算与趋势分析

  • 全球电泳市场：产品仪表板
  • 全球电泳市场：产品差异分析
  • 全球电泳市场：依产品和收益
  • 电泳试剂
  • 电泳系统
  • 凝胶文件系统
  • 软体

第五章电泳市场：按应用估算与趋势分析

  • 2023年及2030年应用市场占有率
  • 细分仪表板
  • 全球电泳市场按应用前景
  • 2018-2030年市场规模、预测及趋势分析

第六章电泳市场：依最终用途分类的估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的全球电泳市场展望
  • 2018-2030年市场规模、预测及趋势分析

第七章电泳市场：区域估计与趋势分析

  • 2023 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 2023年主要企业市场占有率分析
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • GE Healthcare
    • QIAGEN NV
    • Lonza Group Ltd.
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Danaher Corporation
    • Harvard Bioscience, Inc.
    • Shimadzu Corporation
Product Code: GVR-4-68040-344-0

Electrophoresis Market Size & Trends

The global electrophoresis market size was estimated at USD 3,176.46 million in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. This growth is attributed to the increasing prevalence of chronic diseases such as CVD and cancer, increasing industry academia collaborations coupled with the rising need for personalized medicines and technological advancements are major factors driving the market. Furthermore, increasing funding for genomics and proteomics research and rising number of clinical laboratories are likely to drive the market over the forecast period.

The rising prevalence of cancer and infectious diseases is driving the need for early diagnosis. In February 2024, WHO estimated the global cancer burden to reach an estimated number of 35 million new cases by 2050, a 77 % rise to that of 20 million in 2022. This increasing prevalence is driving demand for advanced diagnostic and treatment technologies, including electrophoresis reagents and systems. Electrophoresis is a crucial technique used in cancer research, diagnosis, and monitoring, enabling the separation and analysis of proteins, nucleic acids, and other biomolecules. Lung cancer is the leading cause of cancer death worldwide, accounting for 1.8 million deaths 18.7% of total cancer deaths in 2022.

Collaborations between academic institutions and industry players are fostering innovation in electrophoretic techniques, particularly in the fields of genomics, proteomics, and personalized medicine. These partnerships are leveraging advanced electrophoresis technologies to identify biomarkers, study disease mechanisms at a molecular level, and develop targeted therapies tailored to individual genetic profiles. Moreover, the increasing integration of high-throughput electrophoresis systems in clinical diagnostics and pharmaceutical research is accelerating the development of more precise and efficient analytical methods. In May 2022, a recent study published in the PLOS ONE Journal highlighted the use of gel electrophoresis to identify key proteins associated with tumor progression and molecular specificity in lung cancer subtypes. This technique allowed researchers to distinguish proteins from tumor cells, which can aid in accurate diagnosis and potentially contribute to the development of targeted therapies for specific lung cancer segments.

Technological advancements in electrophoresis kits and reagents have been transformative, enhancing the efficiency, accuracy, and versatility of electrophoretic techniques across various scientific and clinical applications. One key development lies in the formulation of novel gel matrices for gel electrophoresis, which offer improved resolution and faster separation of biomolecules such as DNA, RNA, and proteins. For instance, in September 2022, miniPCR bio, a leading provider of scientific equipment for researchers, introduced the BanditTM STEM Electrophoresis Kit, an innovative educational tool that enables students to construct and operate a fully functional gel electrophoresis device at an affordable price. This kit is designed to promote hands-on learning in the field of STEM education.

The market is further characterized by the integration of automated systems and robotics in electrophoresis platforms which has streamlined laboratory workflows. Automated electrophoresis instruments leverage microfluidic chip-based technology to seamlessly incorporate fluorescence detection, electrophoretic separation, and data analysis of biomolecules like proteins and nucleic acids into a single platform. For instance, the Experion analysis chip employs LabChip technology developed by Caliper Life Sciences, Inc. This microfluidic chip serves as a powerful, miniaturized laboratory, encapsulating the capabilities of multiple larger benchtop analytical instruments. Each chip features a network of microchannels that link the sample wells to a separation channel and buffer wells.

Furthermore, automated gel loading, sample handling, and data analysis processes minimize human error and improve reproducibility, making electrophoresis more accessible and reliable for researchers and clinicians. In addition, advancements in single-cell proteomics and plasma biomarker discovery are also boosting the need for electrophoresis technologies with higher throughput and reproducibility. Automation and miniaturization of electrophoresis workflows are key focus areas to meet these evolving research requirements.

Governments' initiatives, increasing funding, and substantial investments in genomics and proteomics are also driving the market growth. Major initiatives like the Yale Center for Genomics and Proteomics and the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium are providing significant funding to advance genomics and proteomics research. This is driving demand for high-performance electrophoresis reagents and systems to support these efforts. Furthermore, in October 2023, the Government of Canada announced an investment of USD 15 million over 5 years to create the Pan-Canadian Genome Library, the country's first national, centralized genomic data management system. The Library will allow for more personalized treatment of diseases, especially rare diseases. Such initiatives aimed at research building capabilities are poised to drive demand for electrophoresis systems and reagents.

Global Electrophoresis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global electrophoresis market report based on product, application, end use, and region:

  • Electrophoresis Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Electrophoresis Reagents

Protein Electrophoresis Reagents

Nucleic Acid Electrophoresis Reagents

  • Electrophoresis Systems

Gel Electrophoresis Systems

Capillary Electrophoresis Systems

  • Gel Documentation Systems
  • Software
  • Electrophoresis Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Research Applications
  • Diagnostics Applications
  • Quality Control and Process Validation
  • Electrophoresis End use Outlook (Revenue, USD Million, 2018 - 2030)
  • Academic and Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospital & Diagnostic Centers
  • Other End use
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Sweden

Denmark

Norway

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East and Africa

Saudi Arabia

South Africa

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Electrophoresis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Increasing industry academia collaborations
      • 3.2.1.3. Rising need for personalized medicines
      • 3.2.1.4. Technological advancements
      • 3.2.1.5. Increasing funding for genomics and proteomics research
      • 3.2.1.6. Rising number of clinical laboratories
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Untrained personnel
      • 3.2.2.2. Stringent regulations
  • 3.3. Electrophoresis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Electrophoresis Market: Product Estimates & Trend Analysis

  • 4.1. Global Electrophoresis Market: Product Dashboard
  • 4.2. Global Electrophoresis Market: Product Movement Analysis
  • 4.3. Global Electrophoresis Market by Product, Revenue
  • 4.4. Electrophoresis Reagents
    • 4.4.1. Electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Protein Electrophoresis Reagents
      • 4.4.2.1. Protein electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Nucleic Acid Electrophoresis Reagents
      • 4.4.3.1. Nucleic acid electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Electrophoresis Systems
    • 4.5.1. Electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Gel Electrophoresis Systems
      • 4.5.2.1. Gel electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Capillary Electrophoresis Systems
      • 4.5.3.1. Capillary electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Gel Documentation Systems
    • 4.6.1. Gel documentation systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Software
    • 4.7.1. Software market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Electrophoresis Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Electrophoresis Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Research Applications
      • 5.4.1.1. Research applications market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Diagnostics Applications
      • 5.4.2.1. Diagnostics applications market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Quality Control and Process Validation
      • 5.4.3.1. Quality control and process validation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Electrophoresis Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Electrophoresis Market by End Use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Academic and Research Institutes
      • 6.4.1.1. Academic and research institutes market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Pharmaceutical and Biotechnology Companies
      • 6.4.2.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Hospital and Diagnostic Centers
      • 6.4.3.1. Hospital and diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Electrophoresis Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ Reimbursement
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ Reimbursement
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ Reimbursement
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ Reimbursement
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ Reimbursement
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ Reimbursement
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ Reimbursement
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ Reimbursement
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.1. Regulatory framework/ Reimbursement
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.1. Regulatory framework/ Reimbursement
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.1. Regulatory framework/ Reimbursement
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ Reimbursement
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ Reimbursement
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ Reimbursement
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ Reimbursement
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Bio-Rad Laboratories, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Others benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Thermo Fisher Scientific Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Others benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Merck KGaA
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Others benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. GE Healthcare
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Others benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. QIAGEN N.V.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Others benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Lonza Group Ltd.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Others benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Agilent Technologies, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Others benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. PerkinElmer, Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Others benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Danaher Corporation
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Others benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Harvard Bioscience, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Others benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Shimadzu Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Others benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America electrophoresis market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe electrophoresis market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Germany electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 22 UK electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 23 UK electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 26 France electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 27 France electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 35 Denmark electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 38 Sweden electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 41 Norway electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific electrophoresis market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 48 China electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 49 China electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 51 Japan electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 54 India electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 55 India electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 60 Australia electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 63 Thailand electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 66 Latin America electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Brazil electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 70 Brazil electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Argentina electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 72 Argentina electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 73 Argentina electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 74 MEA electrophoresis market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 76 MEA electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 77 MEA electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Africa electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Africa electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Africa electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 84 UAE electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 85 UAE electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 86 UAE electrophoresis market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait electrophoresis market, by product, 2018 - 2030 (USD Million)
  • Table 88 Kuwait electrophoresis market, by application, 2018 - 2030 (USD Million)
  • Table 89 Kuwait electrophoresis market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Electrophoresis market: market outlook
  • Fig. 14 Electrophoresis competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Electrophoresis market driver impact
  • Fig. 20 Electrophoresis market restraint impact
  • Fig. 21 Electrophoresis market strategic initiatives analysis
  • Fig. 22 Electrophoresis market: Product movement analysis
  • Fig. 23 Electrophoresis market: Product outlook and key takeaways
  • Fig. 24 Electrophoresis reagents market estimates and forecast, 2018 - 2030
  • Fig. 25 Protein electrophoresis reagents market estimates and forecast, 2018 - 2030
  • Fig. 26 Nucleic acid electrophoresis reagents market estimates and forecast, 2018 - 2030
  • Fig. 27 Electrophoresis systems market estimates and forecast, 2018 - 2030
  • Fig. 28 Gel electrophoresis systems market estimates and forecast, 2018 - 2030
  • Fig. 29 Capillary electrophoresis systems market estimates and forecast, 2018 - 2030
  • Fig. 30 Gel documentation systems market estimates and forecast, 2018 - 2030
  • Fig. 31 Software market estimates and forecast, 2018 - 2030
  • Fig. 32 Electrophoresis market: Application movement analysis
  • Fig. 33 Electrophoresis market: Application outlook and key takeaways
  • Fig. 34 Research applications market estimates and forecast, 2018 - 2030
  • Fig. 35 Diagnostics applications market estimates and forecast, 2018 - 2030
  • Fig. 36 Quality control and process validation market estimates and forecast, 2018 - 2030
  • Fig. 37 Electrophoresis market: End use movement analysis
  • Fig. 38 Electrophoresis market: End use outlook and key takeaways
  • Fig. 39 Academic and research institutes market estimates and forecasts, 2018 - 2030
  • Fig. 40 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030
  • Fig. 41 Hospital and diagnostic centers market estimates and forecasts, 2018 - 2030
  • Fig. 42 Other end use market estimates and forecasts, 2018 - 2030
  • Fig. 43 Global electrophoresis market: Regional movement analysis
  • Fig. 44 Global electrophoresis market: Regional outlook and key takeaways
  • Fig. 45 Global electrophoresis market share and leading players
  • Fig. 46 North America market share and leading players
  • Fig. 47 Europe market share and leading players
  • Fig. 48 Asia Pacific market share and leading players
  • Fig. 49 Latin America market share and leading players
  • Fig. 50 Middle East & Africa market share and leading players
  • Fig. 51 North America, by country
  • Fig. 52 North America
  • Fig. 53 North America market estimates and forecasts, 2018 - 2030
  • Fig. 54 U.S. key country dynamics
  • Fig. 55 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 56 Canada key country dynamics
  • Fig. 57 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 58 Mexico key country dynamics
  • Fig. 59 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 60 Europe
  • Fig. 61 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 62 UK key country dynamics
  • Fig. 63 UK market estimates and forecasts, 2018 - 2030
  • Fig. 64 Germany key country dynamics
  • Fig. 65 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 66 France key country dynamics
  • Fig. 67 France market estimates and forecasts, 2018 - 2030
  • Fig. 68 Italy key country dynamics
  • Fig. 69 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 70 Spain key country dynamics
  • Fig. 71 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 72 Denmark key country dynamics
  • Fig. 73 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 74 Sweden key country dynamics
  • Fig. 75 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 76 Norway key country dynamics
  • Fig. 77 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 78 Asia Pacific
  • Fig. 79 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 80 China key country dynamics
  • Fig. 81 China market estimates and forecasts, 2018 - 2030
  • Fig. 82 Japan key country dynamics
  • Fig. 83 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 84 India key country dynamics
  • Fig. 85 India market estimates and forecasts, 2018 - 2030
  • Fig. 86 Thailand key country dynamics
  • Fig. 87 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 88 South Korea key country dynamics
  • Fig. 89 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 90 Australia key country dynamics
  • Fig. 91 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 92 Latin America
  • Fig. 93 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 94 Brazil key country dynamics
  • Fig. 95 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 96 Argentina key country dynamics
  • Fig. 97 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 98 Middle East and Africa
  • Fig. 99 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 100 South Africa key country dynamics
  • Fig. 101 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 102 Saudi Arabia key country dynamics
  • Fig. 103 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 104 UAE key country dynamics
  • Fig. 105 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 106 Kuwait key country dynamics
  • Fig. 107 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 108 Market share of key market players- Electrophoresis market